KFDA approves Diovan for Heart Failure

Novartis Korea said that the Korea Food and Drug Administration approved an antihypertensive agent Diovan (valsartan) to treat heart failure in patients who are intolerant of angiotensin-converting-enzyme (ACE) inhibitors, a common type of heart failure therapy.

Diovan, an angiotensin II receptor blocker (ARB), is the top-prescribed ARB franchise in the U.S. after its approval from the US FD...